Ethic Inc. Acquires 505 Shares of Molina Healthcare, Inc $MOH

Ethic Inc. grew its holdings in shares of Molina Healthcare, Inc (NYSE:MOHFree Report) by 15.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,869 shares of the company’s stock after buying an additional 505 shares during the quarter. Ethic Inc.’s holdings in Molina Healthcare were worth $1,149,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of MOH. Price T Rowe Associates Inc. MD grew its stake in shares of Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after buying an additional 1,216,903 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after buying an additional 264,664 shares during the last quarter. Nuveen LLC bought a new position in Molina Healthcare in the first quarter worth approximately $46,441,000. T. Rowe Price Investment Management Inc. grew its stake in Molina Healthcare by 8.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock worth $490,099,000 after purchasing an additional 117,796 shares in the last quarter. Finally, Durable Capital Partners LP grew its stake in Molina Healthcare by 13.1% in the first quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock worth $178,399,000 after purchasing an additional 62,899 shares in the last quarter. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Trading Up 1.3%

MOH opened at $163.16 on Monday. The firm has a market cap of $8.84 billion, a price-to-earnings ratio of 10.10 and a beta of 0.55. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. Molina Healthcare, Inc has a 12 month low of $151.95 and a 12 month high of $359.97. The stock has a fifty day moving average price of $184.20 and a 200-day moving average price of $237.98.

Molina Healthcare (NYSE:MOHGet Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing the consensus estimate of $3.97 by ($2.13). The company had revenue of $11.48 billion during the quarter, compared to the consensus estimate of $10.99 billion. Molina Healthcare had a return on equity of 22.95% and a net margin of 1.98%.The company’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $6.01 earnings per share. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, equities research analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on MOH. Barclays reissued an “underweight” rating and issued a $144.00 price objective (down previously from $185.00) on shares of Molina Healthcare in a research note on Friday. Robert W. Baird dropped their price objective on Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research note on Saturday. Cantor Fitzgerald dropped their price objective on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday. Finally, UBS Group dropped their price objective on Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating on the stock in a research note on Friday. Three investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $203.64.

Get Our Latest Analysis on MOH

Insider Buying and Selling at Molina Healthcare

In other news, Director Ronna Romney sold 700 shares of the business’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares of the company’s stock, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO James Woys acquired 10,000 shares of the stock in a transaction dated Monday, August 4th. The stock was acquired at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.26% of the company’s stock.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.